Clinical impact of a deep learning system for automated detection of missed pulmonary nodules on routine body computed tomography including the chest region

Author(s):  
Kueian Chen ◽  
Ying-Chieh Lai ◽  
Balamuralidhar Vanniarajan ◽  
Pieh-Hsu Wang ◽  
Shao-Chung Wang ◽  
...  
2020 ◽  
Vol 56 (2) ◽  
pp. 2000775 ◽  
Author(s):  
Shuo Wang ◽  
Yunfei Zha ◽  
Weimin Li ◽  
Qingxia Wu ◽  
Xiaohu Li ◽  
...  

Coronavirus disease 2019 (COVID-19) has spread globally, and medical resources become insufficient in many regions. Fast diagnosis of COVID-19 and finding high-risk patients with worse prognosis for early prevention and medical resource optimisation is important. Here, we proposed a fully automatic deep learning system for COVID-19 diagnostic and prognostic analysis by routinely used computed tomography.We retrospectively collected 5372 patients with computed tomography images from seven cities or provinces. Firstly, 4106 patients with computed tomography images were used to pre-train the deep learning system, making it learn lung features. Following this, 1266 patients (924 with COVID-19 (471 had follow-up for >5 days) and 342 with other pneumonia) from six cities or provinces were enrolled to train and externally validate the performance of the deep learning system.In the four external validation sets, the deep learning system achieved good performance in identifying COVID-19 from other pneumonia (AUC 0.87 and 0.88, respectively) and viral pneumonia (AUC 0.86). Moreover, the deep learning system succeeded to stratify patients into high- and low-risk groups whose hospital-stay time had significant difference (p=0.013 and p=0.014, respectively). Without human assistance, the deep learning system automatically focused on abnormal areas that showed consistent characteristics with reported radiological findings.Deep learning provides a convenient tool for fast screening of COVID-19 and identifying potential high-risk patients, which may be helpful for medical resource optimisation and early prevention before patients show severe symptoms.


2019 ◽  
Vol 98 (4) ◽  
pp. 368-377 ◽  
Author(s):  
Cristina González‐Gonzalo ◽  
Verónica Sánchez‐Gutiérrez ◽  
Paula Hernández‐Martínez ◽  
Inés Contreras ◽  
Yara T. Lechanteur ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Zhehao He ◽  
Wang Lv ◽  
Jian Hu

Background. The differential diagnosis of subcentimetre lung nodules with a diameter of less than 1 cm has always been one of the problems of imaging doctors and thoracic surgeons. We plan to create a deep learning model for the diagnosis of pulmonary nodules in a simple method. Methods. Image data and pathological diagnosis of patients come from the First Affiliated Hospital of Zhejiang University School of Medicine from October 1, 2016, to October 1, 2019. After data preprocessing and data augmentation, the training set is used to train the model. The test set is used to evaluate the trained model. At the same time, the clinician will also diagnose the test set. Results. A total of 2,295 images of 496 lung nodules and their corresponding pathological diagnosis were selected as a training set and test set. After data augmentation, the number of training set images reached 12,510 images, including 6,648 malignant nodular images and 5,862 benign nodular images. The area under the P-R curve of the trained model is 0.836 in the classification of malignant and benign nodules. The area under the ROC curve of the trained model is 0.896 (95% CI: 78.96%~100.18%), which is higher than that of three doctors. However, the P value is not less than 0.05. Conclusion. With the help of an automatic machine learning system, clinicians can create a deep learning pulmonary nodule pathology classification model without the help of deep learning experts. The diagnostic efficiency of this model is not inferior to that of the clinician.


Author(s):  
Shuo Wang ◽  
Yunfei Zha ◽  
Weimin Li ◽  
Qingxia Wu ◽  
Xiaohu Li ◽  
...  

AbstractCoronavirus disease 2019 (COVID-19) has spread globally, and medical resources become insufficient in many regions. Fast diagnosis of COVID-19, and finding high-risk patients with worse prognosis for early prevention and medical resources optimization is important. Here, we proposed a fully automatic deep learning system for COVID-19 diagnostic and prognostic analysis by routinely used computed tomography.We retrospectively collected 5372 patients with computed tomography images from 7 cities or provinces. Firstly, 4106 patients with computed tomography images and gene information were used to pre-train the DL system, making it learn lung features. Afterwards, 1266 patients (924 with COVID-19, and 471 had follow-up for 5+ days; 342 with other pneumonia) from 6 cities or provinces were enrolled to train and externally validate the performance of the deep learning system.In the 4 external validation sets, the deep learning system achieved good performance in identifying COVID-19 from other pneumonia (AUC=0.87 and 0.88) and viral pneumonia (AUC=0.86). Moreover, the deep learning system succeeded to stratify patients into high-risk and low-risk groups whose hospital-stay time have significant difference (p=0.013 and 0.014). Without human-assistance, the deep learning system automatically focused on abnormal areas that showed consistent characteristics with reported radiological findings.Deep learning provides a convenient tool for fast screening COVID-19 and finding potential high-risk patients, which may be helpful for medical resource optimization and early prevention before patients show severe symptoms.Take-home messageFully automatic deep learning system provides a convenient method for COVID-19 diagnostic and prognostic analysis, which can help COVID-19 screening and finding potential high-risk patients with worse prognosis.


2021 ◽  
pp. 103865
Author(s):  
Eman Shaheen ◽  
André Leite ◽  
Khalid Ayidh Alqahtani ◽  
Andreas Smolders ◽  
Adriaan Van Gerven ◽  
...  

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e13154-e13154
Author(s):  
Li Bai ◽  
Yanqing Zhou ◽  
Yaru Chen ◽  
Quanxing Liu ◽  
Dong Zhou ◽  
...  

e13154 Background: Many people harbor pulmonary nodules. Such nodules can be detected by low-dose computed tomography (LDCT) during regular physical examinations. If a pulmonary nodule is small (i.e. < 10mm), it is very difficult to diagnose whether it is benign or malignant using CT images alone. To address this problem, we developed a method based on liquid biopsy and deep learning to improve diagnostic accuracy of pulmonary nodules. Methods: Thirty-eight patientsharboring one or more small pulmonary nodules were enrolled in this study. Twenty-nine patients were diagnosed as having cancer (stage I = 21, stage II = 1, stage III = 3, stage IV = 4) using tissue biopsy, while the other 9 patients were diagnosed as having benign tumors or lung diseases other than cancer. For each patient, a blood sample was obtained prior to biopsy, and the cell free DNA (cfDNA) was sequenced using a 451-gene panel to a depth of 20,000×. The unique molecular identifiers (UMI) technique was applied to reduce false positives. Seventeen patients also had full-resolution CT images available. A deep learning system primarily based on deep convolutional neural networks (CNN) was used to analyze these CT images. Results: Sequence analysis of blood samples revealed that 75.8% (22/29) of cancer patients had detectable cancer related mutations, and only 1 of 9 (11.1%) non-cancer patient was found to carry a TP53 mutation. The most frequent mutations seen in cancer patients involved genes TP53 (N = 11), EGFR (N = 7), and KRAS (N = 3) with mutant allele fractions varying from 0.08% to 74.77%. Deep learning analysis of the 17 available CT images correctly identified cancers in 88.2% (15/17) of patients. However, by combining the liquid biopsy and image analysis results, all 17 patients were correctly diagnosed. Conclusions: Deep learning-based analysis of CT images can be applied to early diagnosis of lung cancers; but the accuracy of image analysis, when used alone, is only moderate. Diagnostic accuracy can be greatly improved using liquid biopsy as an auxiliary method in patients with pulmonary nodules.


1998 ◽  
Author(s):  
Samuel G. Armato III ◽  
Maryellen L. Giger ◽  
Catherine J. Moran ◽  
Heber MacMahon ◽  
Kunio Doi

Sign in / Sign up

Export Citation Format

Share Document